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Abstract
Background: Cardiovascular magnetic resonance (CMR) is increasingly used to diagnose myocarditis in adults but
its use in children is not well-established. We sought to describe the presentation, CMR protocol and findings, and
outcomes in a multicenter cohort of children with myocarditis.
Methods: Thirteen hospitals retrospectively identified patients meeting the following inclusion criteria: 1) diagnosis
of myocarditis by the managing physicians, 2) age <21 years, 3) CMR examination within 30 days of presentation,
and 4) no congenital heart disease. Clinical data and test results, including CMR findings, were abstracted from the
medical record.
Results: For the 143 patients meeting inclusion criteria, the median age was 16.0 years (range, 0.1-20.3) and
139 (97 %) were hospitalized at the time of CMR. The median time from presentation to CMR was 2 days (0-28).
The median left ventricular ejection fraction at CMR was 56 % (10-74), with 29 (20 %) below 45 %. The median
right ventricular ejection fraction was 54 % (15-72), with 11 (8 %) below 40 %. There was significant variability
among centers in the types of tissue characterization techniques employed (p < 0.001). Overall, late gadolinium
enhancement (LGE) was used in 100 % of studies, followed by T2-weighted imaging (T2W) in 69 %, first-pass
contrast perfusion (FPP) in 48 %, and early gadolinium enhancement (EGE) in 28 %. Abnormalities were most
common with LGE (81 %), followed by T2W (74 %), EGE (55 %), and FPP (8 %). The CMR study was interpreted as
positive for myocarditis in 117 patients (82 %), negative in 18 (13 %), and equivocal in 7 (5 %), yielding a sensitivity of
82 %. At a median follow-up of 7.1 months (0-87), all patients were alive and 5 had undergone cardiac transplantation.
CMR parameters at presentation associated with persistent left ventricular dysfunction were larger left ventricular
end-diastolic volume and lower left and right ventricular ejection fraction but not abnormal LGE.
Conclusions: Despite significant practice variation in imaging protocol among centers, CMR had a high sensitivity for
the diagnosis of myocarditis in pediatric patients. Abnormalities were most often seen with LGE followed by T2W, EGE,
and FPP. These findings should be useful in designing future prospective studies.
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Backgound
Viral myocarditis is an important cause of morbidity and
mortality in both children and adults [1–4]. It may lead
to acute heart failure, dilated cardiomyopathy, and sud-
den cardiac death. The accurate diagnosis of myocarditis
is challenging because the severity and type of symptoms
is quite variable. Moreover, no single test can confirm or
exclude the diagnosis with certainty. Endomyocardial
biopsy, the most widely accepted standard, still suffers
from sampling errors which reduce sensitivity [5], sub-
optimal interobserver agreement [6], and the risk of
complications [7, 8]. Thus, in practice, history, test re-
sults, and clinical course are all integrated to make the
diagnosis.
Over the past decade, cardiovascular magnetic reson-
ance (CMR) has emerged as an important noninvasive
tool for the diagnosis and monitoring of myocarditis in
adults [9, 10]. In addition to providing reliable measure-
ments of ventricular size and function, CMR myocardial
tissue characterization techniques can assess for inflam-
matory changes such as edema, hyperemia, capillary
leak, and myocyte necrosis [11]. As a result, the use of
CMR in evaluating patients with known or suspected
myocarditis was deemed “appropriate” by a multi-society
consensus group in 2006 [12], and suspected myocarditis
has become one of the most common indications for
CMR in adults [13, 14]. Even with CMR, there is no sin-
gle pathognomonic finding. Rather, it is common prac-
tice to apply the Lake Louise Criteria which requires
abnormalities in 2 of 3 tissue characterization tech-
niques: T2-weighted imaging (T2W) which assesses for
edema, T1-weighted early gadolinium enhancement im-
aging (EGE) which assesses for hyperemia, and late
gadolinium enhancement imaging (LGE) which assesses
for myocyte necrosis and fibrosis [9].
Although one of the earliest reports on the diagnosis
of myocarditis with CMR was in children [15], there are
only a few contemporary pediatric studies, and these are
all single center reports with relatively small sample sizes
[4, 16–18]. We, therefore, sought to describe the clinical
presentation, CMR protocols and findings, and out-
comes in a large, multicenter cohort of children with
myocarditis.
Methods
Patients
This was a retrospective, multicenter study. Investigators
at the coordinating center (Boston Children’s Hospital)
solicited participation from an international group of
pediatric centers through the Society for Cardiovascular
Magnetic Resonance Pediatric/Congenital Research
Working Group. Each center identified all patients who
met the following inclusion criteria: 1) ultimate diagnosis
of myocarditis by the patient’s managing physicians, 2) age
at presentation <21 years, 3) CMR within 30 days of pres-
entation, and 4) no history of congenital heart disease.
The study was approved by each center’s institutional re-
view board, all of which waived the requirement for in-
formed consent.
Data collection
For each patient, centers completed an electronic case in-
formation form produced and managed using Research
Electronic Data Capture (REDCap) [19] electronic data
capture tools that were hosted at Boston Children’s
Hospital. REDCap is a Health Insurance Portability and
Accountability Act compliant, secure web-based applica-
tion designed for data collection and management to sup-
port clinical and translational research. The following
demographic and clinical information were recorded on
the form: 1) center name and location; 2) time from pres-
entation to CMR; 3) patient demographic data at the time
of CMR (age, weight, height); 4) presenting signs and
symptoms; 5) echocardiogram results at presentation, at
the time of CMR, and at the latest follow-up; 6) laboratory
data; 7) CMR procedural data including scanner type, ra-
diofrequency coil, use of sedation and inotropic support,
and sequences; 8) CMR findings at presentation and at
follow-up; 9) endomyocardial biopsy results; 10) clinical
treatment; 11) time from initial CMR to latest follow-up;
and 12) clinical status at latest follow-up.
CMR image analysis
CMR image analysis and interpretation were done by
the performing center in order to best reflect real-world
practice. Visual (non-quantitative) assessment was used
for late gadolinium enhancement (LGE), first-pass perfu-
sion (FPP), and T2-weighted (T2W) imaging. T1-
weighted early gadolinium enhancement (EGE) images
were analyzed using myocardial and skeletal muscle sig-
nal intensity ratios at 1 of the 8 centers performing this
technique; the remainder used visual (non-quantitative)
assessment. The classification of each CMR as positive,
negative, or equivocal for myocarditis was based on the
original interpreting physician’s report. Ventricular
dysfunction at CMR was defined as an ejection frac-
tion ≤45 % for the left ventricle (LV) and ≤40 % for
the right ventricle (RV).
Statistical analysis
Continuous variables were summarized as median and
range, and categorical variables were described with
counts and percentages. Comparisons of the different
centers’ use of endomyocardial biopsy and various CMR
sequences were conducted using the Pearson Chi-Square
test. Ventricular volume and function data between
presentation and follow-up CMR studies, as well as be-
tween those with and without LV dysfunction at follow-
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up, and those with and without LGE at follow-up were
compared using the Mann-Whitney U test. All tests
were performed with a 2-sided type I error rate of 0.05.
Data analyses were performed using SPSS version 21
(IBM Corporation, USA).
Results
A total of 143 patients from 13 centers in 3 countries
met the study’s inclusion criteria. The number of pa-
tients per center ranged from 2 to 33. The patients’ me-
dian age was 16.0 years (range 0.1–20.3, interquartile
range 13.7,16.9) and all had a diagnosis of myocarditis,
as specified by the inclusion criteria. Their clinical data
at presentation are summarized in Table 1, and their initial
echocardiographic data in Table 2. Of note, 139 patients
(97 %) were admitted to the hospital with their initial pres-
entation and had a median stay of 4 days (0-210). Among
these, 77 patients (54 %) were admitted to the intensive
care unit with a median stay there of 2 days (0-30).
In the cohort, 31 patients (22 %) underwent endomyo-
cardial biopsy, of which 17 were reported as positive for
myocarditis, 7 were borderline, and 7 were negative.
Viral polymerase chain reaction testing was performed
on 14 of the biopsies and was positive in 2. There was
no significant difference in the percentage of patients
undergoing biopsy among centers (p = 0.41).
CMR
CMR was performed between June 2006 and January
2015, all on a 1.5 Tesla scanner. The median time from
presentation to CMR examination was 2 days (range 0-
28), with most examinations (137, 96 %) performed within
2 weeks of presentation. Twenty-five examinations (18 %)
were done with sedation (median age 7.2 years (0.1-16.8)),
and 24 (17 %) occurred with the patient receiving intra-
venous inotropic medications. The CMR findings for the
cohort are summarized in Table 3 and typical images are
shown in Fig. 1. All studies included LGE as part of the
examination protocol. However, as shown in Fig. 2 and
Table 3, there was significant practice variation (p < 0.001)
among centers in the use of T2W, FPP, and EGE.
LGE was abnormal (i.e., enhancement present) in 115 of
141 patients (81 %) and the most common patterns were
subepicardial (48 %) and/or midwall (44 %). T2W was ab-
normal in 70 of 95 examinations (74 %), EGE was abnor-
mal in 22 of 37 examinations (60 %), and FPP was
abnormal in 5 of 65 examinations (8 %). Considering only
the 3 techniques which comprise the Lake Louise criteria
for a CMR diagnosis of myocarditis (LGE, T2W, and
EGE) [9], all 3 were performed in 39 studies, and, among
these, 0 techniques were abnormal in 4 patients (11 %), 1
in 6 (15 %), 2 in 13 (33 %), and 3 in 16 (41 %). Thus, 29 of
39 patients (74 %) met the Lake Louise diagnostic stand-
ard of having at least 2 of the 3 techniques positive for
myocarditis. For all patients, the CMR was interpreted as
positive for myocarditis by the reporting physician in 117
patients (82 %), equivocal in 7 (5 %), and negative in 18
(13 %), yielding a sensitivity for an ultimate clinical diag-
nosis of myocarditis of 82 %.
Among the 17 patients with endomyocardial biopsies
positive for myocarditis, LGE was abnormal in 11 of 17,
T2W in 3 of 8, and EGE in 2 of 17. Among the 7 patients
with negative biopsy results, LGE was abnormal in 6 of 7,
T2W in 3 of 4, and EGE in 2 of 2.
Outcomes
After a median follow-up time from initial CMR of
7.1 months (0-87), all patients were alive and 5 had under-
gone cardiac transplantation. Among the transplant-free
Table 1 Subject demographic and clinical data at presentation
(n = 143)
Number (%) or
median (range)
Median age (years) 16.0 (0.1 – 20.3)
Symptoms 142 (99 %)
Chest pain 106 (74 %)
Recent or current viral symptoms 60 (42 %)
Shortness of breath 46 (32 %)
Fatigue 35 (25 %)
Fever 34 (24 %)
Palpitations 18 (13 %)
Syncope 11 (8 %)
Poor feeding 10 (7 %)
Signs of congestive heart failure 18 (13 %)
New gallop rhythm 11 (8 %)
New murmur 4 (3 %)
Abnormal electrocardiogram 125 (87 %)
Ventricular tachycardia/fibrillation 12 (8 %)
Atrial tachycardia 2 (1 %)
Abnormal laboratory data 123 (86 %)
Elevated troponin 93 (65 %)
Elevated C-reactive protein 59 (65 %)
Elevated CK-MB 51 (36 %)
Elevated erythrocyte sedimentation rate 18 (13 %)
Admitted to the hospital 139 (97 %)
Inotropic support 36 (25 %)
Ventilatory support 17 (12 %)
Circulatory support 5 (4 %)
Treatment
Intravenous immunoglobulin 81 (57 %)
Steroids 21(15 %)
Other immunomodulators 8 (6 %)
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survivors, follow-up echocardiographic data on LV systolic
function was available in 112 (78 %). In this group, 44 of
the 53 patients (81 %) with LV dysfunction (mild, moder-
ate, or severe) on their presentation echocardiogram had
normal LV function at their latest follow-up echocardio-
gram. Among the 59 patients who had normal function at
presentation, 3 (5 %) developed dysfunction at latest
follow-up. In other words, 12 patients (11 %) had LV dys-
function at follow-up, 9 of whom had LV dysfunction at
presentation and 3 of whom had previously normal func-
tion. The findings on the initial CMR that were signifi-
cantly associated with LV dysfunction at follow-up
included larger LV end-diastolic volume (median 110 ml/
m2 vs. 86 ml/m2, p = 0.02), lower LV ejection fraction (me-
dian 40 % vs. 58 %, p = 0.003), and lower RV ejection frac-
tion (median 39 % vs. 55 %, p = 0.006). Other CMR
parameters, including the age at initial CMR and abnor-
malities on LGE, T2W, EGE, and FPP, were not signifi-
cantly associated with LV dysfunction at follow-up.
Table 2 Echocardiographic findings at presentation
Number (%)
Left ventricular function
Normal 79 (55 %)
Mildly depressed 35 (25 %)
Moderately depressed 15 (11 %)
Severely depressed 14 (10 %)
Left ventricular regional wall motion abnormalities 33 (23 %)
Right ventricular function
Normal 102 (71 %)
Mildly depressed 5 (4 %)
Moderately depressed 5 (4 %)
Severely depressed 3 (2 %)
Valvar dysfunction (≥moderate)
Tricuspid regurgitation 4 (3 %)
Mitral regurgitation 13 (20 %)
Pulmonary regurgitation 0 (0 %)
Aortic regurgitation 1 (1 %)
Pericardial effusion
None/trivial 135 (94 %)
Small 6 (4 %)
Moderate 1 (1 %)
Table 3 Cardiovascular magnetic resonance findings
Number (%) or
median (range)
Left ventricular end-diastolic volume (ml/m2) 87 (38-222)
Left ventricular ejection fraction (%) 56 (10-74)
Left ventricular ejection fraction <45 % 29 (20 %)
Right ventricular end-diastolic volume (ml/m2) 87 (44-138)
Right ventricular ejection fraction (%) 54 (15-72)
Right ventricular ejection fraction <40 % 11 (8 %)
Late gadolinium enhancement imaging performed 143 (100 %)
Abnormal 115 (80 %)
Distributiona
Subepicardial 69 (48 %)
Midwall 63 (44 %)
Patchy 9 (6 %)
Subendocardial 6 (4 %)
T2-weighted imaging performed 99 (69 %)
Abnormal 70 (74 %)
First-pass perfusion imaging performed 69 (48 %)
Abnormal 5 (8 %)
Early gadolinium enhancement imaging performed 40 (28 %)
Abnormal 22 (60 %)
Final interpretation regarding myocarditis
Positive 117 (82 %)
Negative 18 (13 %)
Equivocal 7 (5 %)
aSome patients had more than 1 pattern of distribution
Fig. 1 Typical findings of myocarditis on CMR. 16-year-old patient with a midwall and subepicardial distribution of increased signal intensity in
the left ventricle on T2-weighted (a), T1-weighted early gadolinium enhancement (b), and late gadolinium enhancement (c) imaging
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A follow-up CMR was conducted in 52 patients at a
median of 6.0 months (0.2-69) after their initial CMR.
The median LV ejection fraction was higher at follow-up
CMR (60 % vs. 56 %, p = 0.016). LGE was performed in
all 52 patients at their follow-up study and was persist-
ently abnormal in 39, persistently negative in 3, changed
from abnormal to negative in 6, and changed from nega-
tive to abnormal in 4. Among patients in whom T2W
was performed at both presentation and follow-up, T2W
was persistently abnormal in 6, persistently negative in
5, and changed from abnormal to negative in 24. EGE
was persistently abnormal in 2, persistently negative in
3, and changed from abnormal to negative in 4. Patients
with abnormal LGE at follow-up had a lower LV ejection
fraction (59 % vs. 65 %, p = 0.002).
Discussion
This is the largest published study to date describing the
CMR findings in children with myocarditis and the only
one that compares CMR protocols across centers.
Among the 13 centers in the study, there was significant
variability in the types of tissue characterization tech-
niques employed, with LGE being the most common
and used by all, followed by T2W, FPP, and EGE. Most
examinations were done within 2 weeks of presentation
and without sedation. LV ejection fraction at CMR was
depressed in 20 % of the patients and RV ejection frac-
tion was depressed in only 8 %. Among the tissue
characterization techniques, the highest rate of abnor-
malities was seen with LGE followed by T2W, EGE, and
FPP. Most patients with depressed LV function at pres-
entation recovered normal function. The only CMR
parameters at presentation associated with persistent
dysfunction were larger LV end-diastolic volume and
lower LV and RV ejection fraction.
CMR is now an established technique for the diagnosis
of myocarditis in adults [9, 12, 20–22]. Its value stems
from tissue characterization capabilities that can detect
processes associated with myocardial inflammation. To
this end, 3 CMR techniques are now most commonly
recommended [9]: 1) T2W for the assessment of intra-
cellular and interstitial edema, 2) EGE for the detection
of capillary leakage and hyperemia, and 3) LGE for the
visualization of cellular necrosis and subsequent fibrosis.
The accuracy of CMR for the diagnosis of myocarditis
varies depending on the population being studied, the
reference criteria used for a diagnosis of myocarditis
(e.g., biopsy), the CMR techniques utilized, and whether
a single or a combination of CMR findings is required.
Sensitivities and specificities of up to 76 % and 96 %, re-
spectively, have been reported when at least 2 of the
above 3 techniques are abnormal and clinical criteria are
used as the gold standard [23]. Newer T1 and T2 map-
ping techniques remove the uncertainty associated with
interpreting relative signal intensities and may lead to fur-
ther improvement in diagnostic performance [16, 24, 25].
CMR can also be helpful for risk stratification to predict
those who will have a more benign disease course [26],
and to identify patients who are more likely to have
adverse events and arrhythmias [21, 27, 28]. Such diagnos-
tic and prognostic data have led to widespread adoption
so that suspected myocarditis now accounts for a large
proportion of adult cases referred for CMR [14].
Fig. 2 Practice variability in CMR protocols. Histogram showing
the percentage of examinations which included T2-weighted (a),
T1-weighted early gadolinium enhancement (b), and late gadolinium
enhancement (c) imaging at each of the 13 centers. The number of
patients enrolled from each center is provided at the bottom of
panel c
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In the pediatric population, however, studies on the
utility of CMR in acute myocarditis are few. Interest-
ingly, one of the earliest reports on the use of CMR in
myocarditis was in children [15]. The authors described
increased myocardial to skeletal muscle signal intensity
ratios in 6 children with myocarditis compared to 5
without. Since then, despite data suggesting increased
use of CMR in children admitted with myocarditis [3],
only a few studies have focused on the use of CMR in
this population [4, 16–18]. The earliest of these by Kern
et al. [18] described LGE in a non-ischemic distribution
in 5 children who presented with chest pain and an
elevated troponin I. A larger study by Sachdeva et al. [4]
reported that half of the 34 children with myocarditis
who underwent CMR had LGE. On univariate analysis,
LGE was not associated with early or late poor outcomes
(mechanical support, heart transplantation, or death);
however, on multivariate analysis adjusting for serum
brain naturetic peptide, severely decreased ejection frac-
tion, performance of CMR, and serum troponin, LGE
was a significant risk factor. In contrast to this study
which only described LGE findings, the 2 other reports
of CMR in children utilized all 3 of the imaging tech-
niques recommended in the Lake Louise criteria. In 20
patients, Mavrogeni et al. [17] found that 80 % had ab-
normalities in at least 2 of the 3 techniques, similar to
the 74 % in our cohort. Moreover, their patients, like
ours, had good outcomes with resolution of LV dysfunc-
tion in most patients and no mortality. The other study
included 25 children [16] and found that only 36 % ful-
filled 2 of 3 criteria. This lower rate of abnormalities
might be explained by less severe disease as only 2 of
their patients had a LV ejection fraction <55 % and many
presented with nonspecific symptoms such as chest pain
without elevated serum cardiac enzymes.
In addition to describing the CMR findings in a larger,
multicenter population compared to the single center
studies mentioned above, our study has important impli-
cations with regard to utilization and future research.
The relatively high prevalence of CMR abnormalities in
children with a clinical diagnosis of myocarditis indicates
that it is a sensitive test and supports CMR use when
the diagnosis is unclear. This would include patients
with new onset chest pain or ventricular arrhythmia in
which the clinical history and test results are equivocal
for myocarditis. Because our study only included pa-
tients with myocarditis, it offers no information regard-
ing the specificity of CMR in children. A prospective
investigation in children with suspected myocarditis is
thus desirable. Our results provide some insights that
should help guide the design of such a study and inform
a feasibility assessment. First, a multicenter effort is
likely required as no single center performed more than
33 CMR scans in young patients with myocarditis over
the entire study period. Second, we found considerable
variation in the CMR protocols among the centers. Pos-
sible reasons for this variation include unfamiliarity with
tissue characterization techniques, which are likely less
commonly used with pediatric CMR indications, and the
lack of a published protocol specifically for children with
suspected myocarditis. Thus, organizers of a prospective
study should not assume that centers will be competent
performing and interpreting all tissue characterization
techniques, and should consider having site education
and validation of test studies before enrollment starts.
Third, our study found relatively high rates of abnormal-
ities using the 3 techniques most commonly advocated
for use in adults with myocarditis—T2W, EGE, and
LGE—and thus these should be included in any pro-
spective study. FPP, however, was low-yield and need not
be included. Fourth, as endomyocardial biopsy was per-
formed in only 22 % of our cohort, a study design that
requires it may be at risk for low enrollment. Finally, in
our study cohort, there were no deaths and 5 cardiac
transplants, and nearly all of the patients had normal LV
function at follow-up. Given this low incidence of poor
outcomes, a study aimed at risk stratification will likely
need a large number of subjects to be sufficiently
powered.
Limitations
As noted above, this study only included patients who had
a clinical diagnosis of myocarditis, precluding an analysis
of CMR specificity. This approach was taken because,
after careful consideration, the participating centers did
not believe they could reliably retrospectively identify all
patients with suspected myocarditis who underwent
CMR. The final diagnosis of myocarditis in this report was
based on the opinion of the patient’s managing physicians.
This definition is often used in studies investigating myo-
carditis [4, 24, 26] because there is no single test with suf-
ficient accuracy, it reflects clinical practice, and it allows
multiple factors to be taken into account. However, it is
possible that the criteria that were applied might vary by
physician and center. Image analysis was based on the
interpretation of the original readers, which may vary
somewhat among readers and centers. Nevertheless, this
approach best reflects real-world practice which was an
important aim of this study. Similarly, most centers used
visual (non-quantitative) assessment for LGE, FPP, EGE,
and T2W imaging which may lead to suboptimal accur-
acy, particularly for the last 2 of these techniques. Given
the small number of patients with LV dysfunction at
follow-up, this study may have lacked sufficient power to
detect some associations between CMR findings at pres-
entation and persistent LV dysfunction. Finally, the study
population likely does not represent the entire clinical
spectrum of myocarditis because of referral bias
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related to CMR. The most severely ill may have been
deemed too unstable or unsuitable (e.g., on mechan-
ical circulatory support) to undergo CMR, and those
with mild disease may not have engendered sufficient
concern to warrant CMR.
Conclusion
In this largest and only multicenter report on CMR use in
children with myocarditis, abnormalities consistent with
myocarditis were common. Information from the study
on CMR utilization, clinical management, imaging proto-
cols, and outcomes should be useful for designing pro-
spective CMR myocarditis studies and the development of
a more standardized imaging protocol in children.
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